| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 27.935 | 22.814 | 18.241 | 16.711 | 12.666 | 6.248 | 8.501 | 13.043 | 15.486 | 2.638 |
| Total Income - EUR | 28.411 | 23.051 | 18.354 | 16.895 | 13.005 | 7.078 | 8.535 | 13.059 | 15.503 | 4.738 |
| Total Expenses - EUR | 9.594 | 13.606 | 9.479 | 12.646 | 9.324 | 6.127 | 6.025 | 11.066 | 12.097 | 2.837 |
| Gross Profit/Loss - EUR | 18.817 | 9.445 | 8.876 | 4.249 | 3.681 | 951 | 2.510 | 1.994 | 3.406 | 1.901 |
| Net Profit/Loss - EUR | 17.965 | 8.979 | 8.692 | 4.080 | 3.551 | 770 | 2.259 | 1.724 | 2.562 | 1.603 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Salubris Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.123 | 1.798 | 1.469 | 1.148 | 839 | 541 | 293 | 41 | 40 | 0 |
| Current Assets | 78.107 | 86.320 | 66.657 | 62.219 | 63.810 | 62.998 | 53.475 | 43.610 | 47.561 | 36.900 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 |
| Receivables | 11.222 | 10.966 | 11.791 | 14.143 | 13.200 | 13.666 | 13.245 | 14.365 | 16.951 | 15.727 |
| Cash | 66.884 | 75.354 | 54.867 | 48.076 | 50.610 | 49.332 | 40.226 | 29.245 | 30.610 | 21.173 |
| Shareholders Funds | 80.828 | 84.294 | 68.517 | 62.292 | 64.637 | 64.181 | 54.378 | 43.463 | 45.893 | 18.752 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 340 | 4.975 | 960 | 2.401 | 1.312 | 633 | 638 | 1.438 | 1.708 | 18.148 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3811 - 3811" | |||||||||
| CAEN Financial Year |
3811
|
|||||||||
Comments - Salubris Srl